Device Trial Radar · NCT06750146
Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
162
Planned (sponsor's estimate)
Start
Jun 19, 2025
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Dec 27, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to highlight the effectiveness of the Hot AXIOS™ stent when used in accordance with standard medical practice on the evolution of the quality of life of patients with malignant biliary stenosis requiring drainage of the bile ducts after failure of ERCP, in the two months after stent placement.
Conditions
- Malignant Biliary Stenosis
Interventions
Hot AXIOS™ Stent and Electrocautery Enhanced Delivery SystemDevice
The Hot AXIOS™ Stent and Electrocautery Enhanced Delivery System is commercially available and can be used to bridge two lumens or organs to create an internal drain, so as to drain the bile ducts in case of failure of ERCP.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quality of Life Measurement - Jaundice DimensionTime frame: 2 months (± 15 days)
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
CHU de Besançon
Besançon, France
Clinique des Cedres, Ramsay Sante
Cornebarrieu, France
CHU Limoges
Limoges, France
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.